Brochure
19 May 2021
Affron®️.- SLEEP
PDF 6.1 MB
SLEEP
Content provided by our supplier
PHARMACTIVE Biotech Products SL
-
ES -
2018On CPHI since
-
3Certificates
-
50 - 99Employees
Company types
Other Content from PHARMACTIVE Biotech Products SL (6)
-
Brochure Portfolio
ADD-ON TO ANTIDEPRESSANTS + IMPROVE MOOD IN TEENAGERS + MENOPAUSAL WOMEN + SLEEP
-
Video Affron®️ . - DEPRESSION, ANXIETY AND SLEEP DISORDERS
Affron®️ is standardized to Lepticrosalides®️, a set of biomolecules responsible for the beneficial effects of affron®️. It has 6 human clinical studies already published, one of which was carried out on adolescents and is internationally patented. It provides robust dose-response evidence with a significant effect in 2 weeks. A recent study showed that affron®️, in combination with antidepressants, is associated with an increase in the effectiveness of the drugs and an improvement in the quality of life of patients, due to a decrease in adverse effects. Affron ®️ may help against depression, anxiety and sleep disorders, and is the biomolecule with the fastest absorption, in just 1 hour. -
Brochure Affron®️.- ADD-ON TO ANTIDEPRESSANTS
ADD-ON TO ANTIDEPRESSANTS -
Brochure Affron®️.- IMPROVE MOOD IN TEENAGERS
IMPROVE MOOD IN TEENAGERS -
Brochure Affron®️.- MENOPAUSAL WOMEN
MENOPAUSAL WOMEN
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance